Target intelligence / Profile preview

Neisseria meningitidis serogroup Y capsular polysaccharide (Serogroup Y CPS)

Target
Serogroup Y CPS
Molecular classification
Polysaccharide, Capsular Polysaccharide, Bacterial Antigen
01

Overview

The *Neisseria meningitidis* serogroup Y capsular polysaccharide is a high-molecular-weight carbohydrate polymer that forms the outer capsule of the bacterium. It is composed of repeating units containing D-glucose and N-acetylneuraminic acid (sialic acid), linked via α(2→6) glycosidic bonds. This capsule is a critical virulence factor, enabling the organism to evade host immune responses and cause invasive diseases. Antibodies targeting this capsular polysaccharide are protective; thus, it serves as a key antigen in vaccine development against *N. meningitidis* infections. The genes responsible for biosynthesis and export of the capsular polysaccharide are clustered at the cps (capsule synthesis locus).

Other names
Group Y capsular polysaccharideNmY CPSSerogroup Y polysaccharide
02

Mechanism of action

Induction of neutralizing antibodies against the capsular polysaccharide, leading to complement-mediated killing and opsonophagocytosis of *N. meningitidis* serogroup Y bacteria.

03

Biological functions

Immune evasionComplement resistancePhagocytosis inhibitionVirulenceAntigen presentation
04

Disease associations

MeningitisSepticemiaInvasive meningococcal diseaseInfection
05

Safety considerations

Vaccine-related adverse reactions (e.g., injection site pain, fever)Rare cases of Guillain-Barré syndrome following vaccination
06

Interacting drugs

Conjugate vaccines (e.g., MenACWY)

1 more in the full profile.

07

Biomarkers

Anti-serogroup Y capsular polysaccharide antibody titers (IgG)Serogroup Y *N. meningitidis* detection in cerebrospinal fluid or blood

Beyond the preview

Go deeper on Neisseria meningitidis serogroup Y capsular polysaccharide (Serogroup Y CPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis serogroup Y capsular polysaccharide (Serogroup Y CPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call